Live Imaging of Neuroinflammation Reveals Sex and Estrogen Effects on Astrocyte Response to Ischemic Injury

Background and Purpose— We sought to develop a model system for live analysis of brain inflammatory response in ischemic injury. Methods— Using a reporter mouse-expressing luciferase gene under transcriptional control of the murine glial fibrillary acidic protein (GFAP) promoter (GFAP-luc mice) and biophotonic/bioluminescent imaging as tools, we developed a model system for in vivo analysis of astrocyte activation/response in cerebral ischemia. Results— Analysis of photon emissions from the brains of living animals revealed marked sex differences in astrocyte response to ischemic injury. The increase in GFAP signals was significantly higher in female mice in the metestrus/diestrus period compared with male transgenic mice (1.71×107±0.19×107 vs 0.92×107±0.15×107, P<0.001). Similar results were obtained by quantitative immunohistochemistry (males vs females: 13.4±0.5 vs 16.96±0.64, P<0.0001). However, astrocyte activation/GFAP signals showed cyclic, estrus-dependent variations in response to ischemic injury. Physiologically higher levels of estrogen and application of pharmacologic doses of estrogen during replacement therapy attenuated GFAP upregulation after stroke. Interestingly, contrary to a positive correlation between the intensities of GFAP signals and infarct size in male mice, no such correlation was observed in any of the experimental groups of female GFAP-luc mice. Conclusions— Our results suggest that GFAP upregulation in ischemic injury may have different functional significance in female and male experimental animals and may not directly reflect the extent of ischemia-induced neuronal damage in female GFAP-luc mice. Using a novel live imaging approach, we demonstrated that the early-phase brain inflammatory response to ischemia may be associated with sex-specific biomarkers of brain damage.

[1]  S. Przedborski,et al.  Inducible Nitric Oxide Synthase Up‐Regulation in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis , 1999, Journal of neurochemistry.

[2]  B. Crain,et al.  Estrogen Receptor Antagonist ICI182,780 Exacerbates Ischemic Injury in Female Mouse , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  S. Lacalle,et al.  Astrocytic reaction to a lesion, under hormonal deprivation , 2007, Neuroscience Letters.

[4]  S. Kohama,et al.  Steroid regulation of tyrosine hydroxylase messenger ribonucleic acid in dopaminergic subpopulations of monkey hypothalamus. , 1995, Endocrinology.

[5]  J. Wegiel,et al.  Contribution of glial cells to the development of amyloid plaques in Alzheimer’s disease , 2004, Neurobiology of Aging.

[6]  M. Herrmann,et al.  Rapid immunoassay for the determination of glial fibrillary acidic protein (GFAP) in serum. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[7]  M. Pekny,et al.  Astrocytic intermediate filaments: lessons from GFAP and vimentin knock-out mice. , 2001, Progress in brain research.

[8]  F. Barone,et al.  Development of tissue damage, inflammation and resolution following stroke: An immunohistochemical and quantitative planimetric study , 1993, Brain Research Bulletin.

[9]  Ueli Aebi,et al.  Intermediate filaments: molecular structure, assembly mechanism, and integration into functionally distinct intracellular Scaffolds. , 2003, Annual review of biochemistry.

[10]  S. Jander,et al.  The role of microglia and macrophages in the pathophysiology of the CNS , 1999, Progress in Neurobiology.

[11]  I. Chaudry,et al.  Tissue compartment-specific role of estrogen receptor subtypes in immune cell cytokine production following trauma-hemorrhage. , 2007, Journal of applied physiology.

[12]  Michael Schroeter,et al.  Inflammation and glial responses in ischemic brain lesions , 1998, Progress in Neurobiology.

[13]  Lingyun Zhu,et al.  Non-invasive imaging of GFAP expression after neuronal damage in mice , 2004, Neuroscience Letters.

[14]  Manfred Herrmann,et al.  Release of Glial Tissue–Specific Proteins After Acute Stroke: A Comparative Analysis of Serum Concentrations of Protein S-100B and Glial Fibrillary Acidic Protein , 2000, Stroke.

[15]  Manfred Herrmann,et al.  Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. , 2003, Restorative neurology and neuroscience.

[16]  D. Maysinger,et al.  Real-time imaging of astrocyte response to quantum dots: in vivo screening model system for biocompatibility of nanoparticles. , 2007, Nano letters.

[17]  M. Chopp,et al.  Sequential neuronal and astrocytic changes after transient middle cerebral artery occlusion in the rat , 1993, Journal of the Neurological Sciences.

[18]  Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury , 2001 .

[19]  N. Kitchen,et al.  Early identification of secondary brain damage in subarachnoid hemorrhage: a role for glial fibrillary acidic protein. , 2006, Journal of neurotrauma.

[20]  C. Finch,et al.  Glial Fibrillary Acidic Protein: Regulation by Hormones, Cytokines, and Growth Factors , 1994, Brain pathology.

[21]  M. Nilsson,et al.  Astrocyte activation and reactive gliosis , 2005, Glia.

[22]  U. Lendahl,et al.  Abnormal Reaction to Central Nervous System Injury in Mice Lacking Glial Fibrillary Acidic Protein and Vimentin , 1999, The Journal of cell biology.

[23]  Á. Párducz,et al.  Gonadal hormones as promoters of structural synaptic plasticity: Cellular mechanisms , 1994, Progress in Neurobiology.

[24]  S. Rivest,et al.  Estradiol Is Required for a Proper Immune Response to Bacterial and Viral Pathogens in the Female Brain 1 , 2005, The Journal of Immunology.

[25]  L. Eng,et al.  Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000) , 2000, Neurochemical Research.

[26]  N. Alkayed,et al.  Role of P450 Aromatase in Sex-Specific Astrocytic Cell Death , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  Jean-Pierre Julien,et al.  Efficient three‐drug cocktail for disease induced by mutant superoxide dismutase , 2003, Annals of neurology.

[28]  T. Morgan,et al.  Increased Synaptic Sprouting in Response to Estrogen via an Apolipoprotein E-Dependent Mechanism: Implications for Alzheimer’s Disease , 1998, The Journal of Neuroscience.

[29]  S. K. Malhotra,et al.  Reactive astrocytes: cellular and molecular cues to biological function , 1997, Trends in Neurosciences.

[30]  Y. Weng,et al.  Differential neuroprotective effects of a minocycline-based drug cocktail in transient and permanent focal cerebral ischemia , 2007, Experimental Neurology.

[31]  J. S. Schneider,et al.  Astrocytic Responses to the Dopaminergic Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Cat and Mouse Brain , 1988, Journal of neuropathology and experimental neurology.

[32]  M. Chopp,et al.  Expression of glial fibrillary acidic protein in areas of focal cerebral ischemia accompanies neuronal expression of 72-kDa heat shock protein , 1995, Journal of the Neurological Sciences.

[33]  Milos Pekny,et al.  Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury , 2006, Proceedings of the National Academy of Sciences.

[34]  R. Struble,et al.  Time course of response to estradiol replacement in ovariectomized mice: Brain apolipoprotein E and synaptophysin transiently increase and glial fibrillary acidic protein is suppressed , 2006, Experimental Neurology.

[35]  L. McCullough,et al.  Estrogen and ischemic neuroprotection: an integrated view , 2003, Trends in Endocrinology & Metabolism.

[36]  H. Nawashiro,et al.  Mice lacking GFAP are hypersensitive to traumatic cerebrospinal injury , 1998, Neuroreport.

[37]  Robert J. Dempsey,et al.  Infarct volume quantification in mouse focal cerebral ischemia: a comparison of triphenyltetrazolium chloride and cresyl violet staining techniques , 2004, Journal of Neuroscience Methods.

[38]  B. Crain,et al.  17beta-estradiol reduces stroke injury in estrogen-deficient female animals. , 1999, Stroke.

[39]  P. Wise,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Neuroprotective Effects of Estradiol in Middle-Aged Female Rats* , 2000 .

[40]  G. Gowing,et al.  Selective Ablation of Proliferating Microglial Cells Exacerbates Ischemic Injury in the Brain , 2007, The Journal of Neuroscience.

[41]  M. Moskowitz,et al.  Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.